NM_138477.4:c.3153G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_138477.4(CDAN1):​c.3153G>A​(p.Glu1051Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0221 in 1,598,168 control chromosomes in the GnomAD database, including 1,583 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.061 ( 649 hom., cov: 33)
Exomes 𝑓: 0.018 ( 934 hom. )

Consequence

CDAN1
NM_138477.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.470

Publications

5 publications found
Variant links:
Genes affected
CDAN1 (HGNC:1713): (codanin 1) This gene encodes a protein that appears to play a role in nuclear envelope integrity, possibly related to microtubule attachments. Mutations in this gene cause congenital dyserythropoietic anemia type I, a disease resulting in morphological and functional abnormalities of erythropoiesis. [provided by RefSeq, Jul 2009]
CDAN1 Gene-Disease associations (from GenCC):
  • anemia, congenital dyserythropoietic, type 1a
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital dyserythropoietic anemia type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital dyserythropoietic anemia
    Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 15-42726361-C-T is Benign according to our data. Variant chr15-42726361-C-T is described in ClinVar as Benign. ClinVar VariationId is 262374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.47 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDAN1NM_138477.4 linkc.3153G>A p.Glu1051Glu synonymous_variant Exon 24 of 28 ENST00000356231.4 NP_612486.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDAN1ENST00000356231.4 linkc.3153G>A p.Glu1051Glu synonymous_variant Exon 24 of 28 1 NM_138477.4 ENSP00000348564.3

Frequencies

GnomAD3 genomes
AF:
0.0613
AC:
9337
AN:
152216
Hom.:
647
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.179
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0243
Gnomad ASJ
AF:
0.0351
Gnomad EAS
AF:
0.0586
Gnomad SAS
AF:
0.0457
Gnomad FIN
AF:
0.00386
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.0454
GnomAD2 exomes
AF:
0.0302
AC:
6660
AN:
220590
AF XY:
0.0292
show subpopulations
Gnomad AFR exome
AF:
0.179
Gnomad AMR exome
AF:
0.0125
Gnomad ASJ exome
AF:
0.0363
Gnomad EAS exome
AF:
0.0654
Gnomad FIN exome
AF:
0.00335
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.0179
AC:
25941
AN:
1445834
Hom.:
934
Cov.:
33
AF XY:
0.0185
AC XY:
13266
AN XY:
717826
show subpopulations
African (AFR)
AF:
0.191
AC:
6317
AN:
33160
American (AMR)
AF:
0.0149
AC:
632
AN:
42342
Ashkenazi Jewish (ASJ)
AF:
0.0385
AC:
991
AN:
25718
East Asian (EAS)
AF:
0.0509
AC:
1980
AN:
38870
South Asian (SAS)
AF:
0.0473
AC:
3953
AN:
83562
European-Finnish (FIN)
AF:
0.00359
AC:
187
AN:
52144
Middle Eastern (MID)
AF:
0.0231
AC:
132
AN:
5706
European-Non Finnish (NFE)
AF:
0.00919
AC:
10148
AN:
1104588
Other (OTH)
AF:
0.0268
AC:
1601
AN:
59744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1447
2894
4340
5787
7234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0614
AC:
9358
AN:
152334
Hom.:
649
Cov.:
33
AF XY:
0.0598
AC XY:
4455
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.179
AC:
7428
AN:
41566
American (AMR)
AF:
0.0242
AC:
371
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0351
AC:
122
AN:
3472
East Asian (EAS)
AF:
0.0587
AC:
304
AN:
5180
South Asian (SAS)
AF:
0.0460
AC:
222
AN:
4830
European-Finnish (FIN)
AF:
0.00386
AC:
41
AN:
10626
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0107
AC:
730
AN:
68030
Other (OTH)
AF:
0.0449
AC:
95
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
422
845
1267
1690
2112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0267
Hom.:
72
Bravo
AF:
0.0673
Asia WGS
AF:
0.0540
AC:
190
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital dyserythropoietic anemia, type I Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Anemia, congenital dyserythropoietic, type 1a Benign:1
Nov 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
5.2
DANN
Benign
0.48
PhyloP100
-0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28661826; hg19: chr15-43018559; API